(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTCQB tier of the OTC Market Group, Inc.  IPOScoop has NO CALL on this offering because it is NOT an IPO; technically, this deal is a secondary offering.) ***Note: The company intends to change its name to “authID.ai” from Ipsidy, Inc.  authID.ai […]

We intend to focus on industries that complement our team’s background and capitalize on our team’s ability to source and acquire a business focused on media, technology or entertainment. (Incorporated in the Cayman Islands) Our sponsor, WCAC1 Sponsor LLC, is an affiliate of Waverley Capital, L.P., a venture capital firm focused solely on the innovation […]

(Note: This is a unit offering. IPOScoop has No Call on this IPO because this is a micro-cap unit offering. The common stock will trade on the NASDAQ under the proposed symbol “DATS” and the warrants under the proposed symbol “DATSW”. Each unit consists of one share of our common stock and one Series A […]

AxonPrime, an affiliate of our sponsor, is a partnership between Dinakar Singh and others affiliated with Axon Capital and Dakin Sloss and others affiliated with Prime Movers Lab LLC. AxonPrime unites Axon Capital’s expertise in global investing in public and private equities with Prime Movers Lab’s leading platform for investing in science and deep technology […]

We intend to focus our efforts on businesses that leverage our management team’s experience in acquiring and operating businesses in the consumer industry. We intend to focus our efforts and will seek to capitalize on our founders’ distinctive and complementary backgrounds to identify, acquire and transformatively impact a target business with a substantial portion of […]

We intend to capitalize on the ability of our management team to identify, acquire, and operate a business in the energy industry in North America, though we reserve the right to pursue an acquisition opportunity in any business or industry. We believe that there is a timely opportunity at this unique inflection point in the […]

We intend to concentrate our efforts identifying businesses in the FinTech industry with an enterprise value of approximately $500 million to $1.0 billion, with particular emphasis on businesses that are providing digital, online or mobile payment solutions, processing and gateway services, point-of-sale technology, consumer engagement platforms and ecommerce or loyalty solutions. We believe the creation, delivery […]

We intend to focus our search in the North American and European industrials sector. (Incorporated in the Cayman Islands) We intend to source initial business combination opportunities through our management team’s extensive network of industrials sector business owners, public and private company executives and board members, investment bankers, private equity and debt investors, high net […]

(Note: IPOScoop has NO Call on this micro-cap unit offering. Each unit consists of one share of common stock and one warrant to buy one share of common stock.) We are a clinical biopharmaceutical company whose first product candidate, RenovoGem, is a drug and device combination of intra-arterial gemcitabine and RenovoCath. The FDA has granted […]

(Note: IPOScoop has No Call on this micro-cap IPO. The company changed the IPO’s terms to a unit offering in an S-1/A filing on Aug. 6, 2021, a shift from its initial plans to offer only shares of common stock. Under the amended terms, the company’s stock will trade under the proposed symbol “DRMA” and […]